secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001641172-25-003740
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics closes $16.1M public offering of 14.4M shares at $1.20/share
------------------------------------------------------------------------------

- Closed sale of 14,375,000 shares of common stock at $1.20/share; underwriters' option exercised in full.
- Net proceeds expected to be approximately $16.1 million after underwriting discounts and expenses.
- Proceeds to be used for working capital and general corporate purposes.
- Canaccord Genuity acted as sole bookrunner; Maxim Group as co-manager of the offering.
- Offering made under existing shelf registration statement S-3 effective Dec 6, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000164117225003740/0001641172-25-003740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000164117225003740/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer